Current Pharmacological Treatments for Childhood Onset OCD
Autor: | Stephanie Eken, Bradley C. Riemann, Sarah G. Turk Karan, Martin E. Franklin |
---|---|
Rok vydání: | 2019 |
Předmět: |
Chronic condition
medicine.medical_specialty Treatment response Neurology business.industry medicine.medical_treatment Treatment development Psychological intervention medicine.disease behavioral disciplines and activities Comorbidity 030227 psychiatry Cognitive behavioral therapy Clinical Practice 03 medical and health sciences Psychiatry and Mental health Clinical Psychology 0302 clinical medicine mental disorders medicine business Psychiatry 030217 neurology & neurosurgery |
Zdroj: | Current Treatment Options in Psychiatry. 6:401-411 |
ISSN: | 2196-3061 |
DOI: | 10.1007/s40501-019-00196-6 |
Popis: | Obsessive-compulsive disorder (OCD) is a chronic condition associated with substantial morbidity, comorbidity, and functional impairment in affected youths. Fortunately, efficacy has been established for multiple pharmacotherapies; however, treatment response remains neither universal nor complete; hence, treatment development efforts continue. This review aims to examine evidence for recent trials examining augmentation strategies for partial responders to serotonin reuptake inhibitors (SRIs), the efficacy of adding D-cycloserine (DCS) to cognitive behavioral therapy (CBT), interventions for OCD symptoms associated with infection, and a meta-analytic view of SRI efficacy and dose-response outcomes. Augmentative treatment with SRIs or additional CBT confers additional benefit in CBT partial responders; however, DCS augmentation does not enhance CBT outcomes. Further treatment development is needed to establish effective interventions for infection-related OCD symptoms, and an SRI dose-response curve does not appear to be evident when examining across multiple SRI trials. Implications of these finding for next-stage research efforts and clinical practice are considered. |
Databáze: | OpenAIRE |
Externí odkaz: |